155 related articles for article (PubMed ID: 30618123)
1. Four lncRNAs associated with breast cancer prognosis identified by coexpression network analysis.
Li J; Gao C; Liu C; Zhou C; Ma X; Li H; Li J; Wang X; Qi L; Yao Y; Zhang X; Zhuang J; Liu L; Wang K; Sun C
J Cell Physiol; 2019 Aug; 234(8):14019-14030. PubMed ID: 30618123
[TBL] [Abstract][Full Text] [Related]
2. Systematic analysis of lncRNA-miRNA-mRNA competing endogenous RNA network identifies four-lncRNA signature as a prognostic biomarker for breast cancer.
Fan CN; Ma L; Liu N
J Transl Med; 2018 Sep; 16(1):264. PubMed ID: 30261893
[TBL] [Abstract][Full Text] [Related]
3. An eight-lncRNA signature predicts survival of breast cancer patients: a comprehensive study based on weighted gene co-expression network analysis and competing endogenous RNA network.
Sun M; Wu D; Zhou K; Li H; Gong X; Wei Q; Du M; Lei P; Zha J; Zhu H; Gu X; Huang D
Breast Cancer Res Treat; 2019 May; 175(1):59-75. PubMed ID: 30715658
[TBL] [Abstract][Full Text] [Related]
4. A novel risk score system for assessment of ovarian cancer based on co-expression network analysis and expression level of five lncRNAs.
Zhao Q; Fan C
BMC Med Genet; 2019 Jun; 20(1):103. PubMed ID: 31182053
[TBL] [Abstract][Full Text] [Related]
5. Comprehensive analysis of the aberrantly expressed lncRNA‑associated ceRNA network in breast cancer.
Tuersong T; Li L; Abulaiti Z; Feng S
Mol Med Rep; 2019 Jun; 19(6):4697-4710. PubMed ID: 31059025
[TBL] [Abstract][Full Text] [Related]
6. Analysis of the miRNA-mRNA-lncRNA network in human estrogen receptor-positive and estrogen receptor-negative breast cancer based on TCGA data.
Xiao B; Zhang W; Chen L; Hang J; Wang L; Zhang R; Liao Y; Chen J; Ma Q; Sun Z; Li L
Gene; 2018 Jun; 658():28-35. PubMed ID: 29518546
[TBL] [Abstract][Full Text] [Related]
7. Novel three‑lncRNA signature predicts survival in patients with pancreatic cancer.
Wu B; Wang K; Fei J; Bao Y; Wang X; Song Z; Chen F; Gao J; Zhong Z
Oncol Rep; 2018 Dec; 40(6):3427-3437. PubMed ID: 30542694
[TBL] [Abstract][Full Text] [Related]
8. Oncogenic long noncoding RNA landscape in breast cancer.
Xu S; Kong D; Chen Q; Ping Y; Pang D
Mol Cancer; 2017 Jul; 16(1):129. PubMed ID: 28738804
[TBL] [Abstract][Full Text] [Related]
9. A lymph node metastasis-related protein-coding genes combining with long noncoding RNA signature for breast cancer survival prediction.
Sui Y; Ju C; Shao B
J Cell Physiol; 2019 Nov; 234(11):20036-20045. PubMed ID: 30950057
[TBL] [Abstract][Full Text] [Related]
10. Identification of novel mRNA-miRNA-lncRNA competing endogenous RNA network associated with prognosis of breast cancer.
Zhong G; Lou W; Yao M; Du C; Wei H; Fu P
Epigenomics; 2019 Oct; 11(13):1501-1518. PubMed ID: 31502865
[No Abstract] [Full Text] [Related]
11. Identification of a RNA-Seq Based 8-Long Non-Coding RNA Signature Predicting Survival in Esophageal Cancer.
Fan Q; Liu B
Med Sci Monit; 2016 Dec; 22():5163-5172. PubMed ID: 28028307
[TBL] [Abstract][Full Text] [Related]
12. Identification of Long Noncoding RNAs as Predictors of Survival in Triple-Negative Breast Cancer Based on Network Analysis.
Li XX; Wang LJ; Hou J; Liu HY; Wang R; Wang C; Xie WH
Biomed Res Int; 2020; 2020():8970340. PubMed ID: 32190687
[TBL] [Abstract][Full Text] [Related]
13. A prognostic 11 long noncoding RNA expression signature for breast invasive carcinoma.
He Y; Li X; Meng Y; Fu S; Cui Y; Shi Y; Du H
J Cell Biochem; 2019 Oct; 120(10):16692-16702. PubMed ID: 31095790
[TBL] [Abstract][Full Text] [Related]
14. A five lncRNA signature for prognosis prediction in hepatocellular carcinoma.
Sun Y; Zhang F; Wang L; Song X; Jing J; Zhang F; Yu S; Liu H
Mol Med Rep; 2019 Jun; 19(6):5237-5250. PubMed ID: 31059056
[TBL] [Abstract][Full Text] [Related]
15. Six-long non-coding RNA signature predicts recurrence-free survival in hepatocellular carcinoma.
Gu JX; Zhang X; Miao RC; Xiang XH; Fu YN; Zhang JY; Liu C; Qu K
World J Gastroenterol; 2019 Jan; 25(2):220-232. PubMed ID: 30670911
[TBL] [Abstract][Full Text] [Related]
16. Comprehensive Analysis of Differentially Expressed Profiles of lncRNAs/mRNAs and miRNAs with Associated ceRNA Networks in Triple-Negative Breast Cancer.
Yang R; Xing L; Wang M; Chi H; Zhang L; Chen J
Cell Physiol Biochem; 2018; 50(2):473-488. PubMed ID: 30308479
[TBL] [Abstract][Full Text] [Related]
17. RNA-Sequencing Data Reveal a Prognostic Four-lncRNA-Based Risk Score for Bladder Urothelial Carcinoma: An in Silico Update.
He RQ; Huang ZG; Li TY; Wei YP; Chen G; Lin XG; Wang QY
Cell Physiol Biochem; 2018; 50(4):1474-1495. PubMed ID: 30359990
[TBL] [Abstract][Full Text] [Related]
18. Identification of survival‑associated key genes and long non‑coding RNAs in glioblastoma multiforme by weighted gene co‑expression network analysis.
Chen X; Pan C; Xu C; Sun Y; Geng Y; Kong L; Xiao X; Zhao Z; Zhou W; Huang L; Song Y; Zhang L
Int J Mol Med; 2019 Apr; 43(4):1709-1722. PubMed ID: 30816427
[TBL] [Abstract][Full Text] [Related]
19. LncRNA and mRNA integration network reconstruction reveals novel key regulators in esophageal squamous-cell carcinoma.
Alaei S; Sadeghi B; Najafi A; Masoudi-Nejad A
Genomics; 2019 Jan; 111(1):76-89. PubMed ID: 29317304
[TBL] [Abstract][Full Text] [Related]
20. Genome-Wide Analysis of Prognostic lncRNAs, miRNAs, and mRNAs Forming a Competing Endogenous RNA Network in Hepatocellular Carcinoma.
Lin P; Wen DY; Li Q; He Y; Yang H; Chen G
Cell Physiol Biochem; 2018; 48(5):1953-1967. PubMed ID: 30092571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
